Medium materiality6/10
BioNTech price target lowered to $132 from $136 at Canaccord
Why it may matterVerify against the original reporting
Target remains above current price; bullish outlook despite downgrade.
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Canaccord Genuity lowered BNTX target to $132 from $136; current price $89.01.
- Canaccord target $132
- Price $89.01
Key facts
- 01
Target: $132
- 02
Posted price: $89.01
- 03
Analyst firm: Canaccord Genuity
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.